Flat urothelial carcinoma in situ of the bladder with glandular differentiation

Human Pathology

Volumn 42, Issue 11, 2011, Pages 1653-1659

  Lopez Beltran, Antonio ^a   Jimenez, Rafael E ^b   Montironi, Rodolfo ^c   Patriarca, Carlo ^d   Blanca, Ana ^a   Menendez, Carmen L ^e   Algaba, Ferran ^f   Cheng, Liang ^g  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b MAYO CLINIC   (United States)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d Melegnano Hospital   (Italy)

^e HOSPITAL DE CABUEÑES   (Spain)

^f FUNDACIÓ PUIGVERT   (Spain)

^g INDIANA UNIVERSITY   (United States)

Author keywords

Adenocarcinoma in situ; Carcinoma in situ; CIS; Glandular differentiation; MUC5A

Indexed keywords

BCG VACCINE; CYTOKERATIN 20; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; MUCIN 1; MUCIN 2; MUCIN 5AC; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P16; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER GROWTH; CARCINOMA IN SITU; CLINICAL ARTICLE; CYSTECTOMY; DISEASE ASSOCIATION; FEMALE; GLANDULAR DIFFERENTIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATECTOMY; PROTEIN AGGREGATION; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA IN SITU; CELL DIFFERENTIATION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MUCIN 5AC; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 80054695845     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.12.024     Document Type: Article

References (30)

1. A.M. O'Brien, and S.J. Urbanski Papillary adenocarcinoma in situ of bladder J. Urol 134 1985 544 546 (Pubitemid 16236399)
2. T.Y. Chan, and J.I. Epstein In situ adenocarcinoma of the bladder Am J Surg Pathol 25 2001 892 899 (Pubitemid 32594982)
3. J.S. Miller, and J.I. Epstein Non-invasive urothelial carcinoma of the bladder with glandular differentiation. Report of 24 cases Am J Surg Pathol 33 2009 1241 1248
4. D.J. Grignon, J.Y. Ro, and A.G. Ayala Primary adenocarcinoma of the urinary bladder: a clinicopathologic analysis of 72 cases Cancer 67 1991 2165 2172
5. L.B. Jacobs, J.D. Brooks, and J.I. Epstein Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder Hum Pathol 28 1997 1152 1157 (Pubitemid 27446601)
6. J.I. Lin, C.H. Tseng, and C. Choy Diffuse cystitis glandularis associated with adenocarcinomatous change Urology 15 1980 411 415 (Pubitemid 10153527)
7. M.R. Melamed, N.G. Vousta, and H. Grabstaldt Natural history and clinical behaviour of in situ carcinoma of the human urinary bladder Cancer 17 1964 1533 1545
8. J.L. Shaw, J. Gislason, and J.E. Imbriglia Transition of cystitis glandularis to primary adenocarcinoma of the bladder J Urol 79 1958 815 822
9. D. Susmano, A.B. Rubenstein, and A.R. Dakin Cystitis glandularis and adenocarcinoma of the bladder J Urol 105 1971 671 674
10. A. Lopez-Beltran, L. Cheng, and L. Andersson Preneoplastic non-papillary lesions and conditions ofthe urinary bladder: an update based on the Ancona International Consultation Virchows Arch 440 2002 3 11 (Pubitemid 34143343)
11. A. Lopez-Beltran, R.J. Luque, A. Moreno, E. Bollito, E. Carmona, and R. Montironi The pagetoid variant of bladder urothelial carcinoma in situ A clinicopathological study of 11 cases Virchows Arch 441 2002 148 153 (Pubitemid 34983981)
12. M.J. Morton, S. Zhang, and A. Lopez-Beltran Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder Clin Cancer Res 13 2007 6232 6236 (Pubitemid 350075085)
13. M.N. Lim, N.V. Adsay, D. Grignon, and A.O. Osunkoya Urothelial carcinoma with villoglandular differentiation: a study of 14 cases Mod Pathol 22 2009 1280 1286
14. P.S. Bullock, D.E. Thoni, and W.M. Murphy The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract Cancer 59 1987 2086 2090 (Pubitemid 17077794)
15. L. Cheng, R. Montironi, and D.G. Bostwick Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma Am J Surg Pathol 23 1999 764 771 (Pubitemid 29307681)
16. F.A. Corica, D.A. Husmann, and B.M. Churchill Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow up Urology 50 1997 427 431
17. P.D. Edwards, R.A. Hurm, and W.H. Jaeschke Conversion of cystitis glandularis to adenocarcinoma J Urol 108 1972 568 570
18. D.A. Grace, and C.C. Winter Mixed differentiation of primary carcinoma of the urinary bladder Cancer 21 1968 1239 1243
19. O.N. Gofrit, D. Pode, and G. Pizov The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Gúerin immunotherapy Urol Oncol 27 2009 258 262
20. C. Patriarca, P. Colombo, and A. Pio Taronna Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1) Int J Surg Pathol 17 2009 99 106
21. E.A. Rakha, R.W.G. Boyce, and D.A. El-Rehim Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer Mod Pathol 18 2005 1295 1304 (Pubitemid 41348648)
22. W.G. McCluggage, R. Shah, L.E. Connolly, and H.A. McBride Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2 Int J Gynecol Pathol 27 2008 92 100 (Pubitemid 351627980)
23. N.V. Adsay, K. Merati, and O. Basturk Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas Am J Surg Pathol 28 2004 839 848 (Pubitemid 38856838)
24. M.T. Sung, A. Lopez-Beltran, and J.N. Eble Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder Mod Pathol 19 2006 1395 1401 (Pubitemid 44624156)
25. H. Steininger, H. Mueller, and L. Marquardt Aberrant expression of CDX2 in metaplastic and inflammatory epithelium of the urinary bladder [letter] Am J Surg Pathol 28 2004 1253 1254
26. V. Kaimaktchiev, L. Terracciano, and L. Tornillo The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas Mod Pathol 17 2004 1392 1399 (Pubitemid 39472995)
27. J.A. Ortiz-Rey, I. Antón Badiola, and P. San Miguel Fraile Expression of CDX2 in urinary bladder and urethra lesions Actas Urol Esp 28 2004 101 105
28. R.W. Werling, H. Yaziji, C.E. Bacchi, and A.M. Gown CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas Am J Surg Pathol 27 2003 303 310 (Pubitemid 36245795)
29. E. Kunze, I. Krassenkova, and A. Fayyazi Tumour-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder Histol Histopathol 23 2008 539 548 (Pubitemid 351552340)
30. S.Z. Ali, D.L. Rosenthal, T.Z. Ali, and J.I. Epstein Atlas of urinary cytopathology with histopathologic correlations. New York; Demos Medical 2010 145